Key Record Dates
ClinicalTrials.gov Identifier: | NCT04224493 |
---|---|
Brief Title: | Study of Tazemetostat in Combination With Lenalidomide and Rituximab Compared to Taxemetostat With Placebo in Participants With Relapsed/Refractory Follicular Lymphoma (SYMPHONY-1) |
First Submitted : | December 12, 2019 |
First Submitted that Met QC Criteria : | January 8, 2020 |
First Posted : | January 13, 2020 |
Last Update Submitted that Met QC Criteria : | May 31, 2023 |
Last Update Posted : | June 2, 2023 (Estimate) |